ATE518542T1 - Zusammensetzung in sprayform mit einer kombination aus einem kortikoid und einem vitamin-d-derivat in einer ölphase - Google Patents

Zusammensetzung in sprayform mit einer kombination aus einem kortikoid und einem vitamin-d-derivat in einer ölphase

Info

Publication number
ATE518542T1
ATE518542T1 AT05770876T AT05770876T ATE518542T1 AT E518542 T1 ATE518542 T1 AT E518542T1 AT 05770876 T AT05770876 T AT 05770876T AT 05770876 T AT05770876 T AT 05770876T AT E518542 T1 ATE518542 T1 AT E518542T1
Authority
AT
Austria
Prior art keywords
corticoid
vitamin
derivative
composition
combination
Prior art date
Application number
AT05770876T
Other languages
English (en)
Inventor
Nathalie Willcox
Sandrine Orsoni
Laurent Chemin Du Camouyer Fredon
Original Assignee
Galderma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Sa filed Critical Galderma Sa
Priority claimed from PCT/EP2005/007972 external-priority patent/WO2005123090A1/en
Application granted granted Critical
Publication of ATE518542T1 publication Critical patent/ATE518542T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT05770876T 2004-06-17 2005-06-15 Zusammensetzung in sprayform mit einer kombination aus einem kortikoid und einem vitamin-d-derivat in einer ölphase ATE518542T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0406611A FR2871698B1 (fr) 2004-06-17 2004-06-17 Composition sous forme de spray comprenant une association d'actifs pharmaceutiques et une phase huileuse
US10/950,650 US20050281749A1 (en) 2004-06-17 2004-09-28 Sprayable compositions comprising a combination of pharmaceutical actives and an oily phase
PCT/EP2005/007972 WO2005123090A1 (en) 2004-06-17 2005-06-15 Composition in spray form comprising a combination of a corticoid and a vitamin d derivative in an oily phase

Publications (1)

Publication Number Publication Date
ATE518542T1 true ATE518542T1 (de) 2011-08-15

Family

ID=34945642

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05770876T ATE518542T1 (de) 2004-06-17 2005-06-15 Zusammensetzung in sprayform mit einer kombination aus einem kortikoid und einem vitamin-d-derivat in einer ölphase

Country Status (8)

Country Link
US (1) US20050281749A1 (de)
CN (1) CN101541328A (de)
AR (1) AR049307A1 (de)
AT (1) ATE518542T1 (de)
ES (1) ES2370907T3 (de)
FR (1) FR2871698B1 (de)
RU (1) RU2007101519A (de)
ZA (1) ZA200700306B (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US20080138296A1 (en) * 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
KR101108439B1 (ko) 2002-10-25 2012-01-31 포믹스 리미티드 화장료 및 약제용 거품제
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
FR2871700B1 (fr) * 2004-06-17 2006-11-17 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, et une phase huileuse
US20080153786A1 (en) * 2006-05-22 2008-06-26 Galderma S.A. Controlled release of drugs into/through the skin
EP1928415A2 (de) * 2005-08-13 2008-06-11 Collegium Pharmaceutical, Inc. Topische abgabe mit einer trägerflüssigkeit
FR2893845B1 (fr) * 2005-11-30 2010-10-29 Galderma Sa Composition sous forme de spray comprenant un corticoide et une phase huileuse
US20080260655A1 (en) * 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
EP1970048A1 (de) * 2007-03-15 2008-09-17 Drug Delivery Solutions Limited Polyaphron topische Zusammensetzung mit Vitamin D
US10265265B2 (en) * 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
EP2008651A1 (de) 2007-06-26 2008-12-31 Drug Delivery Solutions Limited Biologisch erodierbares Patch
FR2917976B1 (fr) * 2007-06-29 2010-05-28 Galderma Sa Composition dermatologique comprenant des vehicules lipidiques de calcitriol, son procede de preparation et son utilisation
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
GB0814713D0 (en) * 2008-08-12 2008-09-17 Thornton & Ross Ltd A method and composition for the control of ectoparasites
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US8871184B2 (en) 2009-10-02 2014-10-28 Foamix Ltd. Topical tetracycline compositions
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
CA2800181C (en) * 2010-06-11 2016-03-15 Leo Pharma A/S A pharmaceutical spray composition comprising a vitamin d analogue and a corticosteroid
US8906397B2 (en) 2011-02-07 2014-12-09 Professional Compounding Centers of America, Ltd Permeation enhancers for topical formulations
US20120201871A1 (en) * 2011-02-07 2012-08-09 Professional Compounding Centers Of America, Ltd. Permeation enhancers with liposomes for topical formulations
US8871811B2 (en) 2011-02-07 2014-10-28 Professional Compounding Centers of America, Ltd Permeation enhancers for topical formulations
CN108273065B (zh) 2011-03-14 2020-07-31 药品配送方案有限公司 一种眼用组合物
MX2014015657A (es) * 2012-07-06 2015-03-20 Leo Pharma As Composicion topica que comprende un polimero formador de pelicula para liberar un ingrediente activo a la piel.
SI2942050T1 (sl) * 2014-05-06 2023-01-31 S.I.I.T. s.r.l. - SERVIZIO INTERNAZIONALE IMBALLAGGI TERMOSALDANTI Razpršljiva oljnata sestava, osnovana na lipotopnih vitaminih skupine D, in uporaba le-teh
CN105193723A (zh) * 2015-10-23 2015-12-30 郑州泰丰制药有限公司 度骨化醇喷雾制剂及其制备方法
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
EP3542788A1 (de) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topische zusammensetzung enthaltend calcipotriol und betamethason dipropionat

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4610978A (en) * 1983-03-22 1986-09-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same
FR2709131B1 (fr) * 1993-08-18 1995-11-10 Cilag Laboratoire Dispositif de distribution d'une substance thérapeutique ou cosmétique dont le véhicule inerte est un polydiorganosiloxane volatil, et composition destinée à être utilisée dans le dispositif.
FR2737118B1 (fr) * 1995-07-28 1997-09-05 Oreal Composition dermatologique ou pharmaceutique, procede de preparation et utilisation
FR2738745B1 (fr) * 1995-09-15 1997-10-24 Cird Galderma Nouvelles compositions a base d'un melange synergetique entre au moins un ligand de vdr et un retinoide, et leurs utilisations
FR2740038B1 (fr) * 1995-10-20 1998-01-02 Lafon Labor Composition pour l'administration transdermique
IT1302275B1 (it) * 1998-09-25 2000-09-05 Giorgio Panin Formulazione di gel idrofobo a base di vitamina e acetato perapplicazione topica.
MXPA01010676A (es) * 1999-04-23 2003-08-20 Leo Pharm Prod Ltd Composicion farmaceutica de vitamina d o un analogo de vitamina d y al menos un corticoesteroide.
IL154888A0 (en) * 2000-10-27 2003-10-31 Leo Pharma As Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid
FR2856301B1 (fr) * 2003-06-23 2007-08-03 Galderma Res & Dev Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile

Also Published As

Publication number Publication date
US20050281749A1 (en) 2005-12-22
ZA200700306B (en) 2007-12-27
AR049307A1 (es) 2006-07-12
FR2871698B1 (fr) 2008-07-04
ES2370907T3 (es) 2011-12-23
RU2007101519A (ru) 2008-07-27
FR2871698A1 (fr) 2005-12-23
CN101541328A (zh) 2009-09-23

Similar Documents

Publication Publication Date Title
ATE518542T1 (de) Zusammensetzung in sprayform mit einer kombination aus einem kortikoid und einem vitamin-d-derivat in einer ölphase
DE602005019461D1 (de) Orale zusammensetzungen mit extrakten von rosmarin und zugehörige verfahren
ATE444327T1 (de) Bisepoxidpolyester und mit bisepoxidpolyesterhaltiger zusammensetzung beschichtete lebensmitteldosen
ATE516797T1 (de) Topische polyaphron-zusammensetzung mit vitamin d und kortikosteroid
DE602005011803D1 (de) Kombinationen aus antimuscarinischen mitteln und corticosteroiden
DE602004015337D1 (de) Verdichter mit rückführung und verfahren
DE602007010936D1 (de) Pestizidzusammensetzung mit einem pyridylethylbenzamidderivat und insektizidverbindung
DE602006007007D1 (de) Wasserfreie sprühzusammensetzungen enthaltend ein partiküläre antitranspirans und ein hautbefeuchtungsmittel
DE602007004401D1 (de) Primerzusammensetzung und beschichteter artikel
ZA200800911B (en) Oil continuous phase cosmetic emulsions with conjugated linoleic acid
CU23871B1 (es) Composiciones y métodos de uso para anticuerpos de dickkopf-1
ZA200609099B (en) Compositions with cyclopropenes and non-hydrocarbon oils
MA29039B1 (fr) Dibenzylamines et derives
DE602007013240D1 (de) Zusammensetzung mit sarsasapogenin
DE602007009443D1 (de) Nanodrahtzusammensetzung und Herstellungsverfahren dafür
DE602007004220D1 (de) Neue pyridazinverbindung und ihre verwendung
FR2896333B1 (fr) Autotransformateur a dephasage de 20[
DE502007001209D1 (de) Wachszusammensetzung und deren Verwendung
DE102005013572B8 (de) Schmierölzusammensetzung und deren Verwendung
ATE446301T1 (de) Ausgewählte kondensierte heterocyclen und deren anwendung
DE502005008944D1 (de) Antihaftschicht aus vernetzten Nanopartikeln
DE602005013909D1 (de) Kosmetische zusammensetzung mit einer lipidfraktion aus einer pflanzlichen quelle und anti-kristallisationsmittel
GB0700895D0 (en) Hoki fish liver oil,fractions thereof and therapeutic uses
FI20060186A (fi) Uudet koostumukset ja menetelmät niiden valmistamiseksi
DE602005015209D1 (de) Zusammensetzungen aus einem glycosaminoglykan und einem nichtsteroidalen antirheumatikum

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties